Postmortem redistribution of fentanyl in the rabbit blood

American Journal of Forensic Medicine and Pathology

Volumn 33, Issue 2, 2012, Pages 119-123

  Ceelen, Liesbeth ^a   De Zwart, Loeckie ^b   Voets, Marieke ^b   Hillewaert, Vera ^b   Monbaliu, Johan ^b   Teuns, Greet ^b   Coussement, Werner ^b   Greway, Tony ^c  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Durogesic pain patch; fentanyl; postmortem redistribution; rabbit

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ANIMAL; ARTICLE; BLOOD; CADAVER; FEMALE; FORENSIC TOXICOLOGY; INTRADERMAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RABBIT; RANDOMIZATION; STATISTICAL MODEL;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; ANIMALS; CHROMATOGRAPHY, LIQUID; FEMALE; FENTANYL; FORENSIC TOXICOLOGY; LINEAR MODELS; MASS SPECTROMETRY; POSTMORTEM CHANGES; RABBITS; RANDOM ALLOCATION;

EID: 84861231984     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAF.0b013e3181fbbb49     Document Type: Article

References (23)

1. Trescott AM, Datta S, Lee M, et al. Opioid pharmacology. Pain Physician. 2008;11:S133-S153.
2. Janssen PA. Potent, new analgesics, tailor made for different purposes. Acta Anaesthesiol Scand. 1982;26:262-268.
3. Muijsers RBR, Wagstaff AJ. Transdermal fentanyl: An updated review of its pharmacological and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61:2290-2307.
4. Pelissier-Alicot AL, Gaulier JM, Champsaur P, et al. Mechanisms underlying postmortem redistribution of drugs: A review. J Anal Toxicol. 2003;27:533-544.
5. Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology. 1989;70:928-934.
6. Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol (Phila). 2005;43:235-241.
7. Leikin JB, Watson WA. Postmortem toxicology: What the dead can and cannot tell us. J Toxicol Clin Toxicol. 2003;41:47-56.
8. Jung BE, Reidenberg MM. Interpretation of opioid levels: Comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Ther. 2005;77:324-334.
9. Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood samples: The influence of postmortem redistribution. J Clin Pathol. 2000;53:282-285.
10. Ferner RE. Postmortem clinical pharmacology. Br J Clin Pharmacol. 2008;66:430-443.
11. Anderson DT, Mutto JJ. Durogesic\ transdermal patch: Postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000;24:627-634.
12. Thompson JG, Baker AM, Bracey AH, et al. Fentanyl concentrations in 23 postmortem cases from the Hennepin County medical examiner's office. J Forensic Sci. 2007;52:978-981.
13. Luckenbill K, Thompson J, Middleton O, et al. Fentanyl postmortem redistribution: Preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations. J Anal Toxicol. 2008;32:639-643.
14. Woodall KL, Martin TL, McLellan BA. Oral abuse of fentanyl patches (Durogesic\): Seven case reports. J Forensic Sci. 2008;53: 222-225.
15. Olson KN, Luckenbill K, Thompson J, et al. Postmortem redistribution of fentanyl in blood. Am J Clin Pathol. 2010;133: 447-453.
16. Foley PL, Henderson AL, Bissonette EA, et al. Evaluation of fentanyl transdermal patches in rabbits: Blood concentrations and physiological response. Comp Med. 2001;51:239-244.
17. Pelissier-Alicot AL, Gaulier JM, Dupuis C, et al. Postmortem redistribution of three beta-blockers in the rabbit. Int J Legal Med. 2006;120:226-232.
18. De Letter EA, Clauwaert KM, Belpaire FM, et al. Postmortem redistribution of 3,4-methylenedioxymethamphetamine (MNDA Becstasy[) in the rabbit. Part 1: Experimental approach after in vivo infusion. Int J Legal Med. 2002;116:216-224.
19. Hess R, Herz A, Friedel K. Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect. J Pharmacol Exp Ther. 1971;179:474-484.
20. Hess R, Stiebler G, Herz A. Pharmacokinetics of fentanyl in man and the rabbit. Eur J Clin Pharmacol. 1972;4:137-141.
21. Leclercq L, Cuyckens F, Mannens GSJ, et al. Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development. Chem Res Toxicol. 2009;22: 280-293.
22. Meuldermans WE, Hurkmans RM, Heykants JJ, et al. Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. Arch Int Pharmacodyn Ther. 1982;257:4-19.
23. Ilkiw JE, Benthuysen JA, McNeal D. Comparative study of the pharmacokinetics of alfentanil in rabbits, sheep, and dogs. Am J Vet Res. 1991;52:581-584.